Dr. Cheryl E. Balkman, DVM
Cornell University
College of Veterinary Medicine
C3-506 CPC
Ithaca, NY 14853
P: (607) 253-4134
F: (607) 253-3055
ceb11@cornell.edu
Cheryl E. Balkman, DVM
Diplomate - American College of Veterinary Internal Medicine
Lecturer, Section of Oncology
Research/Clinical Interests
Chemotherapy drug resistance in cancer patients. Hematopoietic Malignancies.
Education and Training
1998 Cornell College of Veterinary Medicine, DVM
Board Certification
2004 American College of Veterinary Internal Medicine
Selected Publications
Wakshlag JJ, Balkman CE. Effects of lycopene on proliferation and death of canine osteosarcoma cells. Am J Vet Res. 2010; Nov;71 (11): 1362-70. PMID: 21034328.
Flory AB, Rassnick KM, Balkman CE, Kiselow MA, Autio K, Beaulieu BB, Lewis LD. Oral bioavailability of etoposide after administration of a single dose to tumor-bearing dogs. Am J Vet Res. 2008; Oct;69 (10): 1316-22. PMID: 18828689.
Rassnick KM, Muindi JR, Johnson CS, Balkman CE, Ramnath N, Yu WD, Engler KL, Page RL, Trump DL. In vitro and in vivo evaluation of combined calcitriol and cisplatin in dogs with spontaneously occurring tumors. Cancer Chemother Pharmacol. 2008; Oct; 62 (5):881-91. Epub 2008 Feb 2. PMID: 18246349.
Rassnick KM, McEntee MC, Erb HN, Burke BP, Balkman CE, Flory AB, Kiselow MA, Autio K, Gieger TL. Comparison of 3 protocols for treatment after induction of remission in dogs with lymphoma. J Vet Intern Med. 2007; Nov-Dec; 21 (6): 1364-73. PMID: 18196748.
